{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:47:07Z","timestamp":1790567227619,"version":"4.1.0"},"reference-count":40,"publisher":"Federacion Colombiana de Obstetricia y Ginecologia","issue":"1","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["revista.fecolsog.org"],"crossmark-restriction":false},"short-container-title":["Rev. Colomb. Obstet. Ginecol."],"abstract":"<jats:p>Objetivos: proveer recomendaciones cl\u00ednicas basadas en evidencia para la prevenci\u00f3n y el manejo de la \u00a0enfermedad hipertensiva del embarazo EHE en EsSalud.\nMateriales y m\u00e9todos: se conform\u00f3 un grupo elaborador de la gu\u00eda (GEG) que incluy\u00f3 m\u00e9dicos especialistas y metod\u00f3logos. El GEG formul\u00f3 ocho preguntas cl\u00ednicas para ser respondidas por la presente Gu\u00eda de Pr\u00e1ctica Cl\u00ednica (GPC). Se realizaron b\u00fasquedas sistem\u00e1ticas de revisiones sistem\u00e1ticas y, cuando se consider\u00f3 pertinente, estudios primarios en PubMed y Central durante 2021. Se seleccion\u00f3 la evidencia para responder cada una de las preguntas cl\u00ednicas planteadas. La certeza de la evidencia fue evaluada usando la metodolog\u00eda. En reuniones de trabajo peri\u00f3dicas, el GEG us\u00f3 la metodolog\u00eda Grading of Recommendations Assessment, Development, and Evaluation (GRADE) para calificar\u00a0 la evidencia y formular las recomendaciones. Adem\u00e1s se resentan los puntos de buenas pr\u00e1cticas cl\u00ednicas (BPC) y los flujogramas de prevenci\u00f3n, manejo y seguimiento. Finalmente, la GPC fue aprobada por Resoluci\u00f3n 112-IETSI-ESSALUD-2021.\nResultados:\u00a0en la presente GPC se formularon 11 recomendaciones (6 fuertes y 5 condicionales) que respondieron las preguntas cl\u00ednicas definidas en el alcance de la GPC, acompa\u00f1adas de 32 BPC y 3 flujogramas que abordan temas de prevenci\u00f3n tratamiento y seguimiento de la EHE\nConclusiones: como recomendaciones centrales de la gu\u00eda se dan el uso de sulfato de magnesio para el tratamiento de la preeclampsia severa y la eclampsia. La gu\u00eda deber\u00e1 ser actualizada en tres a\u00f1os.<\/jats:p>","DOI":"10.18597\/rcog.3810","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T14:13:24Z","timestamp":1650723204000},"page":"48-141","update-policy":"https:\/\/doi.org\/10.18597\/crossmark","source":"Crossref","is-referenced-by-count":9,"title":["Gu\u00eda de pr\u00e1ctica cl\u00ednica para la prevenci\u00f3n y el manejo de la enfermedad hipertensiva del embarazo"],"prefix":"10.18597","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3431-2016","authenticated-orcid":false,"given":"Omar","family":"Yanque-Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5706-7351","authenticated-orcid":false,"given":"Naysha","family":"Becerra-Chauca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8012-1520","authenticated-orcid":false,"given":"Wendy","family":"Nieto-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-5489","authenticated-orcid":false,"given":"Ra\u00fal","family":"Alegr\u00eda Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6611-4006","authenticated-orcid":false,"given":"Marco","family":"Uriarte-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-5264","authenticated-orcid":false,"given":"Wilmer","family":"Valencia-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-9537","authenticated-orcid":false,"given":"Jorge","family":"Arroyo-Campuzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-1884","authenticated-orcid":false,"given":"Lourdes Sheillah","family":"Torres-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-5464","authenticated-orcid":false,"given":"Rita Ada","family":"Meza-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-9026","authenticated-orcid":false,"given":"Carmen","family":"Meza-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-6644","authenticated-orcid":false,"given":"Stefany","family":"Salvador-Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6852-2601","authenticated-orcid":false,"given":"Lourdes","family":"Carrera-Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7913","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"89200","unstructured":"Urquiza JPN, \u00c1vila MTS, Garza LAM, Nava VMS. Enfermedad hipertensiva del embarazo. Med Crit. 2010;24(4):190-5."},{"key":"89201","doi-asserted-by":"crossref","unstructured":"Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre\u2010eclampsia: A pragmatic guide for first\u2010trimester screening and prevention. Int J Gynecol Obstet. 2019;145:1-33. https:\/\/doi.org\/10.1002\/ijgo.12802","DOI":"10.1002\/ijgo.12892"},{"key":"89202","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez SE. Actualizaci\u00f3n en la epidemiolog\u00eda de la preeclampsia: update. Rev Per Ginecol Obstet. 2014;60(4):309-20. https:\/\/doi.org\/10.31403\/rpgo.v60i155","DOI":"10.31403\/rpgo.v60i155"},{"key":"89203","unstructured":"Seguro Social de Salud EsSalud. EsSalud: 8 % de aseguradas embarazadas sufren Preeclampsia, principal causa de muerte materna Lima: EsSalud; 2014. Disponible en: http:\/\/www.essalud.gob.pe\/essalud-8-de-aseguradas-embarazadas-sufren-preeclampsia-principal-causa-de-muerte-materna\/."},{"key":"89204","unstructured":"Centro Nacional de Epidemiolog\u00eda Prevenci\u00f3n y Control de Enfermedades. Bolet\u00ecn Epidemiol\u00f3gico. Lima: Ministerio de Salud; 2020."},{"key":"89205","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, 222. Obstet Gynecol. 2020;135(6):e237-e60. https:\/\/doi.org\/10.1097\/AOG.0000000000003891","DOI":"10.1097\/AOG.0000000000003891"},{"key":"89206","doi-asserted-by":"crossref","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008","DOI":"10.1136\/bmj.j4008"},{"key":"89207","doi-asserted-by":"crossref","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J clin epidemiol. 2011;64(4):401-6. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.07.015","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"89208","doi-asserted-by":"crossref","unstructured":"Alonso-Coello P, Sch\u00fcnemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016. https:\/\/doi.org\/10.1136\/bmj.i2016","DOI":"10.1136\/bmj.i2016"},{"key":"89209","doi-asserted-by":"crossref","unstructured":"Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: A systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016;353:i2089. https:\/\/doi.org\/10.1136\/bmj.i2089","DOI":"10.1136\/bmj.i2089"},{"key":"89210","doi-asserted-by":"crossref","unstructured":"Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol. 2018;218(3):287-93.e1. https:\/\/doi.org\/10.1016\/j.ajog.2017.11.561","DOI":"10.1016\/j.ajog.2017.11.561"},{"key":"89211","doi-asserted-by":"crossref","unstructured":"Roberge S, Sibai B, McCaw-Binns A, Bujold E. Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: Meta-analysis of large randomized trials. Am J Perinatol. 2016;33(8):781-5. https:\/\/doi.org\/10.1055\/s-0036-1572495","DOI":"10.1055\/s-0036-1572495"},{"key":"89212","doi-asserted-by":"crossref","unstructured":"Cui Y, Zhu B, Zheng F. Low-dose aspirin at \u226416 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis. Exp Ther Med. 2018;15(5):4361-9. https:\/\/doi.org\/10.3892\/etm.2018.5972","DOI":"10.3892\/etm.2018.5972"},{"key":"89213","doi-asserted-by":"crossref","unstructured":"Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia? Am J Obstet Gynecol. 2020;222(5):437-50. https:\/\/doi.org\/10.1016\/j.ajog.2019.08.047","DOI":"10.1016\/j.ajog.2019.08.047"},{"key":"89214","doi-asserted-by":"crossref","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM. Antiplatelet agents for preventing pre\u2010eclampsia and its complications. Cochrane Database of Systematic Reviews. 2019(10). https:\/\/doi.org\/10.1002\/14651858.CD004659.pub3","DOI":"10.1002\/14651858.CD004659.pub3"},{"key":"89215","doi-asserted-by":"crossref","unstructured":"Van Doorn R, Mukhtarova N, Flyke IP, Lasarev M, Kim K, Hennekens CH, et al. Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis. PLoS One. 2021;16(3):e0247782. https:\/\/doi.org\/10.1371\/journal.pone.0247782","DOI":"10.1371\/journal.pone.0247782"},{"key":"89216","doi-asserted-by":"crossref","unstructured":"Turner JM, Robertson NT, Hartel G, Kumar S. Impact of low-dose aspirin on adverse perinatal outcome: Meta-analysis and meta-regression. Ultrasound Obstet Gynecol. 2020;55(2):157-69. https:\/\/doi.org\/10.1002\/uog.20859","DOI":"10.1002\/uog.20859"},{"key":"89217","unstructured":"Organisation WH. Recommendations on drug treatment for non-severe hypertension in pregnancy. Geneva: WHO; 2020."},{"key":"89218","unstructured":"Instituto Nacional Materno Perinatal. Gu\u00eda de Pr\u00e1ctica Cl\u00ednica para la prevenci\u00f3n y manejo de la preeclampsia y eclampsia - Versi\u00f3n Extensa. Lima: Unidad de An\u00e1lisis y Geenraci\u00f3n de Evidencia en Salud P\u00fablica; 2017."},{"key":"89219","doi-asserted-by":"crossref","unstructured":"Duley L, G\u00fclmezoglu AM, Henderson\u2010Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre\u2010eclampsia. Cochrane database of systematic reviews. 2010(11). https:\/\/doi.org\/10.1002\/14651858.CD000025.pub2","DOI":"10.1002\/14651858.CD000025.pub2"},{"key":"89220","doi-asserted-by":"crossref","unstructured":"Shepherd E, Salam RA, Manhas D, Synnes A, Middleton P, Makrides M, et al. Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis. PLoS medicine. 2019;16(12):e1002988. https:\/\/doi.org\/10.1371\/journal.pmed.1002988","DOI":"10.1371\/journal.pmed.1002988"},{"key":"89221","doi-asserted-by":"crossref","unstructured":"Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. The Cochrane database of systematic reviews. 2013;2013(7):Cd001449. https:\/\/doi.org\/10.1002\/14651858.CD001449.pub3","DOI":"10.1002\/14651858.CD001449.pub3"},{"key":"89222","doi-asserted-by":"crossref","unstructured":"Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: A systematic review. BJOG. 2014;121(10):1210-8; discussion 20. https:\/\/doi.org\/10.1111\/1471-0528.12737","DOI":"10.1111\/1471-0528.12737"},{"key":"89223","doi-asserted-by":"crossref","unstructured":"Shekhar S, Gupta N, Kirubakaran R, Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: A systematic review and meta-analysis. BJOG. 2016;123(1):40-7. https:\/\/doi.org\/10.1111\/1471-0528.13463","DOI":"10.1111\/1471-0528.13463"},{"key":"89224","doi-asserted-by":"crossref","unstructured":"Alavifard S, Chase R, Janoudi G, Chaumont A, Lanes A, Walker M, et al. First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis. Pregnancy hypertension. 2019;18:179-87. https:\/\/doi.org\/10.1016\/j.preghy.2019.09.019","DOI":"10.1016\/j.preghy.2019.09.019"},{"key":"89225","doi-asserted-by":"crossref","unstructured":"Antza C, Dimou C, Doundoulakis I, Akrivos E, Stabouli S, Haidich AB, et al. The flipside of hydralazine in pregnancy: A systematic review and meta-analysis. Pregnancy Hypertens. 2020;19:177-86. https:\/\/doi.org\/10.1016\/j.preghy.2020.01.011","DOI":"10.1016\/j.preghy.2020.01.011"},{"key":"89226","unstructured":"World Health Organization. WHO recommendations Policy of interventionist versus expectant management of severe pre-eclampsia before term. Geneva: WHO; 2018."},{"key":"89227","unstructured":"Excellence NIfHaC. Hypertension in pregnancy: Diagnosis and management. London: NICE; 2019."},{"key":"89228","doi-asserted-by":"crossref","unstructured":"Duley L, Henderson\u2010Smart DJ, Walker GJ, Chou D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database of Systematic Reviews. 2010(12). https:\/\/doi.org\/10.1002\/14651858.CD000127.pub2","DOI":"10.1002\/14651858.CD000127.pub2"},{"key":"89229","doi-asserted-by":"crossref","unstructured":"Duley L, Henderson\u2010Smart DJ, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews. 2010(10). https:\/\/doi.org\/10.1002\/14651858.CD000128.pub2","DOI":"10.1002\/14651858.CD000128.pub2"},{"key":"89230","doi-asserted-by":"crossref","unstructured":"Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev. 2010(9):Cd008148. https:\/\/doi.org\/10.1002\/14651858.CD008148.pub2","DOI":"10.1002\/14651858.CD008148.pub2"},{"key":"89231","doi-asserted-by":"crossref","unstructured":"Berks D, Steegers EAP, Molas M, Visser W. Resolution of hypertension and proteinuria after preeclampsia. Obstet Gynecol. 2009;114(6):1307-14. https:\/\/doi.org\/10.1097\/AOG.0b013e3181c14e3e","DOI":"10.1097\/AOG.0b013e3181c14e3e"},{"key":"89232","doi-asserted-by":"crossref","unstructured":"Furuta M, Sandall J, Bick D. Women's perceptions and experiences of severe maternal morbidity\u2014a synthesis of qualitative studies using a meta-ethnographic approach. Midwifery. 2014;30(2):158-69. https:\/\/doi.org\/10.1016\/j.midw.2013.09.001","DOI":"10.1016\/j.midw.2013.09.001"},{"key":"89233","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: Diagnosis and management. UK: NICE; 2019."},{"key":"89234","doi-asserted-by":"crossref","unstructured":"Conti-Ramsden FI, Nathan HL, Greeff AD, Hall DR, Seed PT, Chappell LC, et al. Pregnancy-related acute kidney injury in preeclampsia. Hypertension. 2019;74(5):1144-51. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13089","DOI":"10.1161\/HYPERTENSIONAHA.119.13089"},{"key":"89235","doi-asserted-by":"crossref","unstructured":"Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, et al. Association between obesity and cardiovascular outcomes: A systematic review and meta-analysis of mendelian randomization studies. JAMA Network Open. 2018;1(7):e183788-e. https:\/\/doi.org\/10.1186\/1471-2393-14-134","DOI":"10.1001\/jamanetworkopen.2018.3788"},{"key":"89236","doi-asserted-by":"crossref","unstructured":"Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29(3):294-300. https:\/\/doi.org\/10.3109\/10641950902777747","DOI":"10.3109\/10641950902777747"},{"key":"89237","doi-asserted-by":"crossref","unstructured":"Benschop L, Duvekot JJ, Versmissen J, Broekhoven Vv, Steegers EAP, Lennep JERv. Blood Pressure Profile 1 Year After Severe Preeclampsia. Hypertension. 2018;71(3):491-8. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10338","DOI":"10.1161\/HYPERTENSIONAHA.117.10338"},{"key":"89238","doi-asserted-by":"crossref","unstructured":"Unverdi S, Ceri M, Unverdi H, Yilmaz R, Akcay A, Duranay M. Postpartum persistent proteinuria after preeclampsia: A single-center experience. Wien Klin Wochenschr. 2013;125(3-4):91-5. https:\/\/doi.org\/10.1007\/s00508-013-0320-8","DOI":"10.1007\/s00508-013-0320-8"},{"key":"89239","unstructured":"EsSalud. Documento T\u00e9cnico Orientador: Atenci\u00f3n Preconcepcional en el Seguro Social de Salud. En: Gerencia Central de Prestaciones de Salud, editor. Per\u00fa: EsSalud; 2020."}],"container-title":["Revista Colombiana de Obstetricia y Ginecolog\u00eda"],"original-title":[],"link":[{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3810\/3767","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3810\/3766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T19:36:50Z","timestamp":1668627410000},"score":1,"resource":{"primary":{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/view\/3810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3,30]]}},"URL":"https:\/\/doi.org\/10.18597\/rcog.3810","relation":{},"ISSN":["2463-0225","0034-7434"],"issn-type":[{"value":"2463-0225","type":"electronic"},{"value":"0034-7434","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"2022-03-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Federaci\u00f3n Colombiana de Obstetricia y Ginecolog\u00eda","name":"publisher","label":"This article is maintained by"},{"value":"Revista Colombiana de Obstetricia y Ginecolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculo de Revisi\u00f3n","name":"content_type","label":"Content Type"}]}}